These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 17958006)
1. [Short telomere length a marker of premature vascular aging]. Nilsson PM; Fyhrquist F Lakartidningen; 2007 Sep 26-Oct 2; 104(39):2801-5. PubMed ID: 17958006 [No Abstract] [Full Text] [Related]
2. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Matthews C; Gorenne I; Scott S; Figg N; Kirkpatrick P; Ritchie A; Goddard M; Bennett M Circ Res; 2006 Jul; 99(2):156-64. PubMed ID: 16794190 [TBL] [Abstract][Full Text] [Related]
3. Biological ageing and cardiovascular disease. Samani NJ; van der Harst P Heart; 2008 May; 94(5):537-9. PubMed ID: 18411343 [No Abstract] [Full Text] [Related]
4. Telomere length and cardiovascular aging: the means to the ends? De Meyer T; Rietzschel ER; De Buyzere ML; Van Criekinge W; Bekaert S Ageing Res Rev; 2011 Apr; 10(2):297-303. PubMed ID: 21109027 [TBL] [Abstract][Full Text] [Related]
5. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Minamino T; Komuro I Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):637-48. PubMed ID: 18762784 [TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle cell senescence in atherosclerosis. Gorenne I; Kavurma M; Scott S; Bennett M Cardiovasc Res; 2006 Oct; 72(1):9-17. PubMed ID: 16824498 [TBL] [Abstract][Full Text] [Related]
7. [Telomeres and biological ageing in cardiovascular disease]. Huzen J; van Veldhuisen DJ; van Gilst WH; van der Harst P Ned Tijdschr Geneeskd; 2008 May; 152(22):1265-70. PubMed ID: 18590060 [TBL] [Abstract][Full Text] [Related]
8. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Erusalimsky JD; Kurz DJ Exp Gerontol; 2005; 40(8-9):634-42. PubMed ID: 15970413 [TBL] [Abstract][Full Text] [Related]
9. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. Aviv A J Mol Med (Berl); 2002 Nov; 80(11):689-95. PubMed ID: 12436345 [TBL] [Abstract][Full Text] [Related]
10. Telomere attrition as ageing biomarker. Bekaert S; De Meyer T; Van Oostveldt P Anticancer Res; 2005; 25(4):3011-21. PubMed ID: 16080560 [TBL] [Abstract][Full Text] [Related]
11. Cellular responses to telomere shortening: cellular senescence as a tumor suppressor mechanism. Greider CW Harvey Lect; 2000-2001; 96():33-50. PubMed ID: 12200870 [No Abstract] [Full Text] [Related]
12. Mechanisms of telomere maintenance and attrition: linking cancer and ageing. Hengstler JG; Marchan R; Bolt HM Arch Toxicol; 2009 May; 83(5):405-6. PubMed ID: 19390840 [No Abstract] [Full Text] [Related]
13. Angiotensin II-type 2 receptor: emerging target for cardiovascular protection. Schmieder RE Am J Hypertens; 2010 Mar; 23(3):220. PubMed ID: 20154649 [No Abstract] [Full Text] [Related]
14. Aging, telomeres, and atherosclerosis. Edo MD; Andrés V Cardiovasc Res; 2005 May; 66(2):213-21. PubMed ID: 15820190 [TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction in subcutaneous small resistance arteries and cardiovascular events. Zoccali C J Hypertens; 2006 Sep; 24(9):1900-1; author reply 1901-2. PubMed ID: 16915043 [No Abstract] [Full Text] [Related]
20. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. Nilsson PM; Lurbe E; Laurent S J Hypertens; 2008 Jun; 26(6):1049-57. PubMed ID: 18475139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]